Rocket Lab Corp [RKLB] Stock sold by Insider Saintil Merline for $8.31 million

Jaxson Clark

In a filing, Rocket Lab Corp revealed its Director Saintil Merline unloaded Company’s shares for reported $8.31 million on Jan 13 ’26. In the deal valued at $86.58 per share,96,000 shares were sold. As a result of this transaction, Saintil Merline now holds 292,529 shares worth roughly $28.17 million.

Then, Saintil Merline sold 12,500 shares, generating $1,125,000 in total proceeds. Upon selling the shares at $90.00, the Director now owns 280,029 shares.

Before that, MERLINE A SAINTIL bought 12,500 shares. Rocket Lab Corp shares valued at $1,082,250 were divested by the Director at a price of $86.58 per share.

Morgan Stanley upgraded its Rocket Lab Corp [RKLB] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who decreased its forecast for the stock in mid January from “an Overweight” to “a Sector weight”. Needham also remained covering RKLB and reiterated its “Buy” recommendation on November 12, 2025. Robert W. Baird started covering the stock on October 16, 2025. It rated RKLB as “an Outperform”.

Price Performance Review of RKLB

On Friday, Rocket Lab Corp [NASDAQ:RKLB] saw its stock jump 6.10% to $96.3. Over the last five days, the stock has gained 13.49%. Rocket Lab Corp shares have risen nearly 287.21% since the year began. Nevertheless, the stocks have risen 38.04% over the past one year.

How much short interest is there in Rocket Lab Corp?

A steep rise in short interest was recorded in Rocket Lab Corp stocks on 2025-12-31, dropping by -5.72 million shares to a total of 39.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 45.2 million shares. There was a decline of -14.48%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on July 28, 2025 when Craig Hallum began covering the stock and recommended ‘”a Hold”‘ rating along with a $51 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.